Key result
Concomitant PFA with LAAO is linked to ~78% lower small peridevice leak risk vs RFA.
Why the study?
Concomitant pulmonary vein isolation and left atrial appendage occlusion is increasingly performed in AF patients, but the impact of pulsed field ablation versus radiofrequency ablation on peridevice leak and procedural efficiency is unclear.
Does concomitant pulsed field ablation and left atrial appendage occlusion reduce peridevice leak and procedural duration compared to radiofrequency ablation and left atrial appendage occlusion in patients with atrial fibrillation?
Cohort (n=175)
No
Does concomitant pulsed field ablation and left atrial appendage occlusion reduce peridevice leak and procedural duration compared to radiofrequency ablation and left atrial appendage occlusion in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Concomitant pulsed field ablation and left atrial appendage occlusion significantly reduces the incidence of 45-day peridevice leak and shortens procedure time compared to radiofrequency ablation.
BACKGROUND: Concomitant pulmonary vein isolation (PVI) and left atrial appendage occlusion (LAAO) is increasingly performed in patients with atrial fibrillation (AF) at elevated thromboembolic risk. Radiofrequency ablation (RFA) has been the conventional approach, but pulsed field ablation (PFA) may reduce tissue edema, procedural duration, and peridevice leak (PDL). OBJECTIVE: To compare safety, efficacy, and PDL rates between PFA + LAAO and RFA + LAAO. METHODS: In this single-center, retrospective study, 175 consecutive patients undergoing LAAO with or without concomitant PVI between September 2021 and May 2025 were included: RFA + LAAO (n = 61), PFA + LAAO (n = 39), and LAAO-only (n = 75). Procedural data, device characteristics, and complications were collected. The primary endpoint was PDL at 45-day follow-up transesophageal echocardiography (TEE). Secondary endpoints included procedure duration, vascular and esophageal complications, device-related thrombosis, and arrhythmia recurrence. RESULTS: Baseline characteristics were generally balanced, although RFA + LAAO patients were younger. No large PDL (> 5 mm) was observed. At 45 days, small PDL (≤ 5 mm) was significantly higher in RFA + LAAO (23%) vs. PFA + LAAO (5.1%) and LAAO-only (9.3%; p = 0.015). Mean procedure duration was shorter with PFA + LAAO (67.1 ± 10.4 min) compared with RFA + LAAO (99.6 ± 12.8 min; p < 0.001). Major complications and device-related thrombosis were rare. Minor complications and AF recurrence were comparable across groups. CONCLUSIONS: Concomitant PFA + LAAO is associated with lower PDL incidence and shorter procedural times compared with RFA + LAAO, without compromising safety.
No takes yet. Share an insight, caveat, or question.
Atasi et al. (2026) conducted a cohort in Atrial fibrillation (n=175). Pulsed field ablation (PFA) + LAAO vs. Radiofrequency ablation (RFA) + LAAO was evaluated on Small peridevice leak (≤ 5 mm) at 45-day follow-up transesophageal echocardiography (p=0.015). Concomitant pulsed field ablation and left atrial appendage occlusion was associated with a lower incidence of small peridevice leak at 45 days compared to radiofrequency ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: